Active-ingredient Dossier
Bosentan Monohydrate
Active-ingredient Dossier for Bosentan Monohydrate (endothelin receptor antagonist). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: BOSENTAN VIATRIS
- Brand: BOSENTAN
- Brand: BOSENTAN DR.REDDY'S
- Brand: BOSENTAN
- Brand: BOSENTAN-REDDY'S
- Brand: BOSLEER
- Therapeutic area: Cardiology
- Therapeutic area: Rare Disease
What is
Bosentan Monohydrate Bosentan Monohydrate is an endothelin receptor antagonist.
Australian brands containing
Bosentan Monohydrate — BOSENTAN — BOSENTAN VIATRIS — BOSENTAN DR.REDDY'S — BOSENTAN GH — TRACLEER — BOSENCIP — BOSENTAS
Therapeutic areas
Bosentan Monohydrate is registered in cardiology, with 12 brands containing this ingredient on the ARTG.
Sponsor landscape
Eight sponsors market bosentan monohydrate in Australia, including Cipla, Arrotex Pharmaceuticals, Dr Reddys Laboratories, Sun Pharma, Accord Healthcare and Generic Health.
PBS and regulatory activity
One brand containing bosentan monohydrate has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 March 2008. No AusPARs are on record for bosentan monohydrate.